baber/WOPTO huggingface dataset:
Patent CA-2426190-A1 (CA)
Inventor: LE TAM KIEN
IPC: A01K69/08
Filed: 2003-04-22
Abstract: A round crab pot provides crabs easy access from all directions, while strongly discouraging exit except by crabs of nonallowable small size. The pot may be of variable weight and size for commercial or individual use. The pot frame has an interchangeable top and bottom kept parallel by perpendicular supporting posts. The pot entrance occupies the entire height and circumference. The entrance is formed by a plurality of elongated spring steel rods connected to the top and/or bottom of the frame. The rods are positioned to slant inwardly toward the center of the pot and are connected by spring steel wire and a thin plastic medium. Thus, the entrance exhibits a spring-like tension as crabs enter. In a first variation, the rods are connected to only one end of the frame. Crabs may enter at ground level with the rods extending from the top of the pot, slanting inward and downward toward the center. By reversing the top and bottom, crabs may enter by walking up the rods. Rods of a lesser length may be attached to both the top and bottom of the pot. Crabs walk up the rods to the midpoint of the height of the pot and drop into the center. In both variations, the rods will not allow the crabs to exit.
Patent CA-2426781-A1 (CA)
Title: Bace1 promoter sequences
Inventor: SONG WEIHONG
IPC: C12Q1/68
Filed: 2003-05-09
Abstract: Proteolytic processing of the .beta.-amyloid precursor protein (APP) at the .beta. site is essential to generate .alpha..beta. BACE (or BACE1), the major .beta.-secretase involved in cleaving APP, has been identified as a type 1 membrane-associated aspartyl protease. We have cloned a 2.1 kb fragment upstream of the human BACE gene and identified key regions necessary for promoter activity. BACE gene expression is controlled by a TATA-less promoter. The region of -619 bp to +46 bp is the minimal promoter to control the transcription of the BACE gene. Several putative cis-acting elements such as a GC box, HSF-1, PU-box, AP1, AP2, and lymphokine response element are found in the 5' flanking region of the BACE gene.       Transcriptional activation and Gel Shift assays demonstrated that the BACE promoter contains a functional Sp1 response element and overexpression of the transcription factor Sp1 potentiates the BACE gene expression and APP processing to generate A.beta.. These results suggest that the BALE gene expression is tightly regulated at the transcriptional level and the transcription factor Sp1 plays a central role in regulation of BACE to process APP generating .ALPHA..beta.  in Alzheimer's Disease (AD).
Patent CA-2430315-A1 (CA)
Title: Cholesterol lowering supplement
Inventor: VAN DER BURGT LEONTINE MARTINA
IPC: A23L1/30
Filed: 2001-11-29
Abstract: The invention provides a composition and a method for lowering blood serum cholesterol levels or for preventing elevated blood serum cholesterol levels, as well as a suitable composition comprising (a) one or more phytosterols and/or phytostanols capable of reducing cholesterol absorption in the intestine and/or one more soluble fibres capable of inhibiting ileal bile acid absorption, (b) a composition capable of inhibiting cholesterol biosynthesis, and (c) a composition capable of increasing cholesterol metabolism, wherein at least one of compositions (b) and (c) is preferably derived from plants.
Patent CA-2432572-A1 (CA)
Title: Oxybenzamides derivatives as factor xa inhibitors
Inventor: GERLACH UWE
IPC: A61P7/02
Filed: 2001-12-15
Abstract: The present invention relates to compounds of the formula I, R0~-Q-X-Q'-W-U-V-G-M (I) in which R0; Q; X; Q'; W; U, V, G and M have the meanings indicated in the claims. The compounds of the formula I are valuable pharmacologically active compounds. They exhibit a strong antithrombotic effect and are suitable, for example, for the therapy and prophylaxis of cardiovascular disorders like thromboembolic diseases or restenoses. They are reversible inhibitors of the blood clotting enzymes factor Xa (Fxa) and/or factor VIIa (FVIIa), and can in general be applied in conditions in which an undesired activity of factor Xa and/or factor VIIa is present or for the cure or prevention of which an inhibition of factor Xa and/or factor VIIa is intended.  The invention furthermore relates to processes for the preparation of compounds of the formula I, their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical preparations comprising them.
Patent CA-2434730-A1 (CA)
Title: Low humidity uptake solid pyrotechnic compositions, and methods for making the same
Inventor: BLAU REED J
IPC: C06B31/08
Filed: 2002-01-11
Abstract: A solid pyrotechnic composition having a flame temperature and exhibiting ballistic performance comparable to that of black powder, but which is preferably formulated to contain neither charcoal nor sulfur, is provided. A  solid pyrotechnic composition having a flame temperature and exhibits ballistic performance comparable to that of boron/potassium nitrate, and that is preferably free of boron, is also provided.
Patent CA-2435514-A1 (CA)
Inventor: TAMMINGA JACOB R
IPC: B01F29/85
Filed: 2003-07-18
Abstract: A vertical mixer has a set of wheels on each side of the mixer that is automatically adjustable for variation in the terrain where the mixer is used. Each set is rotatable about a pivot point. Preferably, weight bars provide the pivot point for each set of wheels. There is a further weight bar in the tongue of the mixer. The weight bars automatically determine the weight of materials within the mixer on an intermittent or continuous basis.
Patent CA-2436021-A1 (CA)
Inventor: JOHNSON BRUCE D
IPC: E06B1/36
Filed: 2003-07-24
Abstract: The cable support apparatus includes a cleat mountable to support structure for having one end of a cable laced thereto and mechanism for supporting a load. The cleat includes a longitudinal elongated base having transversely opening jam lugs, hook lugs with the jam lugs longitudinally intermediate thereof and end lugs joined thereto. The jam lug longitudinally intermediate the longitudinally adjacent jam lugs in combination with the base forms generally V-shaped notches that open outwardly in transversely opposite directions. With the cleat mounted to have the lugs vertically above one another, the top hook lug opens transversely opposite the opening of the adjacent jam lug whereby, with the cable extending diagonally upwardly from the last mentioned jam lug to the hook lug, the cable is then bent to extend through the transverse aperture in the top end lug.
Patent CA-2438963-A1 (CA)
Inventor: WANG YUN-CHENG
IPC: G02C9/04
Filed: 2003-08-29
Abstract: A combination device for attaching auxiliary spectacles (50) to main spectacles (40) has a base (10), a clip (20) and a resilient member (30). The base (10) is mounted on the nose bridge (52) of the auxiliary spectacles (50) and has a recess (12) with an opening. The clip (20) is pivotally attached to the base (10) to close of the opening of the recess (12). The clip (20) has a length longer than that of the base (10) and an inclined surface (28) formed on the distal end of the clip (20). The resilient member (30) is mounted between the base (10) and the clip (20) to provide a restitution force to the clip (20). Accordingly, a user can operate, without using hands, the combination device to attach or detach the auxiliary spectacles (50) onto or from the main spectacles (40) conveniently.
Patent CA-2440495-A1 (CA)
Title: Laser pulmonary vein isolation
Inventor: YARON URI
IPC: A61B18/24
Filed: 2003-09-11
Abstract: A catheter introduction apparatus provides an optical assembly for emission of laser light energy. In one application, the catheter and the optical assembly are introduced percutaneously, and transseptally advanced to the ostium of a pulmonary vein. An anchoring balloon is expanded to position a mirror near the ostium of the pulmonary vein, such that light energy is reflected and directed circumferentially around the ostium of the pulmonary vein when a laser light source is energized. A circumferential ablation lesion is thereby produced, which effectively blocks electrical propagation between the pulmonary vein and the left atrium.
Patent CA-2441398-A1 (CA)
Inventor: VIELLEVOYE MARCEL
IPC: C07D295/14
Filed: 2002-03-27
Abstract: Biphenylcarboxamide compounds of formula (I), methods for preparing such compounds, pharmaceutical compositions comprising said compounds as well as the use of said compounds as a medicine for the treatment of hyperlipidemia, obesity and type II diabetes.
Patent CA-2446183-A1 (CA)
Title: A controller for providing an efficient dormant mode for a group communication network
Inventor: MAGGENTI MARK
IPC: H04B7/26
Filed: 2002-05-14
Abstract: A method and apparatus for providing an efficient dormant mode for push-to-talk communication devices (102, 104, 106) in a group communication network (100) provides for determining whether the net has been inactive for a predetermined first time period and, if so, causing each member of the net to enter a control-hold mode, wherein each member of the net maintains its dedicated traffic channel. The method further includes the steps of determining whether each member of the net has been in the control-hold mode for a predetermined second time period and, if so, causing each member of the net to enter a dormant mode, wherein each member of the net releases its dedicated traffic channel. The method and apparatus further provides for causing each member of the net to cache its service configuration state before entering the dormant mode.
Patent CA-2446352-A1 (CA)
Inventor: HARPER JOHN MICHAEL
IPC: A47B88/493
Filed: 2003-10-23
Abstract: A shelf overlay for mounting to a shelving system having at least one horizontal shelf mounted at opposite ends of the shelf to a pair of parallel and vertical spaced apart shelving standards. At least one such shelf overlay is mountable onto corresponding shelves. Each shelf overlay includes a rigid planar portion, a lip, and mounting means.  The rigid planar portion is bounded by a front edge, an oppositely disposed rear edge, and opposite side edges. The lip is orthogonal to the planar portion and is mounted along the front edge so as to extend from each of the opposite side edges. The lip extends downwardly from the planar portion so as to substantially cover a front edge surface of a corresponding shelf when the shelf overlay is mounted onto the corresponding shelf. The lip may also extend upwardly from the planar portion. The lip may be planar or may be convexly curved in a horizontal plane.
Patent CA-2446403-A1 (CA)
Title: Amelioration de la qualite du son dans des systemes de telephonie par ordinateur
Inventor: SKUBNIK BIANKA
IPC: H04M3/40
Filed: 2002-04-16
Abstract: L'invention concerne des techniques pour améliorer la qualité du son dans des systèmes de téléphonie par ordinateur. D'une manière générale, les signaux numériques comprenant des sons téléphoniques sont convertis du domaine temps au domaine fréquence. Si l'on détecte du bruit lors de la conversion des signaux numériques au domaine fréquence, le bruit est enlevé au moyen d'un filtre. La détection du bruit et le filtrage peuvent se faire au moyen d'un logiciel de manière à obtenir une qualité audio améliorée à un coût relativement réduit et avec une flexibilité relativement élevée pour des environnements assez variés.
Patent CA-2446997-A1 (CA)
Inventor: JONES CURT D
IPC: A23P1/02
Filed: 2002-03-15
Abstract: The present invention is directed to a novel method for manufacturing popcorn-shaped frozen product, such as but not limited to ice cream. Unlike prior systems that manufactured small, beaded frozen product, the method of the present invention introduces a much larger (diametrically larger) quantity of liquid composition into the liquid refrigerant, the freezing processes changes substantially, to give the final product a popcorn shape.
Patent CA-2447116-A1 (CA)
Title: Methods for treating liver disease and liver damage with growth hormone and foxm1b
Inventor: COSTA ROBERT H
IPC: C12N5/08
Filed: 2002-05-17
Abstract: The invention provides a method of treating liver damage or disease in a patient by stimulating liver regeneration. Specifically, the invention provides a method of inducing liver cell proliferation comprising contacting liver cells that express FoxM1B protein with growth hormone. The invention also provides methods of screening for compounds that induce FoxM1B protein expression, nuclear localization, or both expression and nuclear localization.  The invention further provides pharmaceutical compositions comprising selected compounds and methods of using such compositions.
Patent CA-2448617-A1 (CA)
Title: Borehole fluid
Inventor: TEIGEN ASLAK
IPC: C09K8/36
Filed: 2002-04-08
Abstract: A water-in-oil emulsion bore hole fluid comprising oil, a brine and emulsifier wherein the oil-to-brine ratio by weight is between 10:90 and 30:70. The emulsifier has a high molecular weight in the range from 500 up to 5000 and a suitable HLB balance.
Patent CA-2449840-A1 (CA)
Inventor: SHERRILL LAURA K
IPC: A23K1/00
Filed: 2002-06-05
Abstract: An animal chew toy for carnivorous animals and a method for making the animal chew toy. The animal chew toy is primarily for dogs, and is safe, entertainment, and satisfies their inherent and instinctive need to chew. The chew toy is particularly safe for older dogs, dogs with weak jaws, and puppies with relatively new teeth. The chew toy is formed into a desired shape from a rawhide bit mixture of rawhide bits or pieces and a bonding agent and/or adherent. A plurality of flavor chunks, for example jerky pieces, are interspersed in the rawhide bit mixture to provide an enticing flavor and aroma that encourages an animal to continue to chew to reveal more flavor chunks. The rawhide bit mixture can further include health affecting additives. One method of forming the chew toy includes extrusion molding which can be coupled with baking or heat-treating to destroy unhealthy pathogens and solidify the chew toy. An elongated jerky member may be encased within the chew toy.
Patent CA-2451445-A1 (CA)
Title: Imidazo-triazine derivatives as ligands for gaba receptors
Inventor: CARLING WILLIAM ROBERT
IPC: A61P25/28
Filed: 2002-07-08
Abstract: A class of 7-phenylimidazo[1,2-b][1,2,4]triazine derivatives, substituted at the meta position of the phenyl ring by a (cyano)(fluoro)phenyl moiety, being selective ligands for GABAA receptors, in particular having good affinity for the .alpha.2 and/or .alpha.3 subunit thereof, are accordingly of benefit in the treatment and/or prevention of adverse conditions of the central nervous system, including anxiety and convulsions.
Patent CA-2455524-A1 (CA)
Title: Low thermal expansion adhesives and encapsulants for cryogenic and high power density electronic and photonic device assembly and packaging
Inventor: STARKOVICH JOHN A
IPC: H01L23/29
Filed: 2004-01-21
Abstract: Filled composite compositions can be used as encapsulants, underfill materials, and potting materials in electronic and optical packages that are subjected to a wide temperature range. The composites contain a matrix and a filler composition.  In a preferred embodiment, the matrix is an organic material. The filler composition contains particles of a material that have a negative coefficient of thermal expansion.  The filler composition contains particles having a wide range of sizes. Furthermore, the particles exhibit a non-normal, for example, log normal or power-law, particle distribution. The non-normal size distribution of the particles enables the filler composition to be formulated at high levels into organic matrices, resulting in composites that have very low coefficient of thermal expansion to match those of the semiconductor materials in the electronic package or optical components in an optical assembly.
Patent CA-2457835-A1 (CA)
Title: Crystalline forms of valacyclovir hydrochloride
Inventor: WIZEL SHLOMIT
IPC: C07D473/18
Filed: 2002-09-06
Abstract: Provided are novel polymorphs and pseudopolymorphs of valacyclovir hydrochloride and phamaceutical compositions containing these. Also provided are methods for making the novel polymorphs and pseudopolymorphs, which include valacyclovir hydrochloride monohydrate and valacyclovir hydrochloride dihydrate.
Patent CA-2461387-A1 (CA)
Title: A process for the contamination-tolerant bonding of substrates
Inventor: SCHENKEL HUBERT
IPC: B29C65/48
Filed: 2004-03-19
Abstract: The introduction of vibration energy into the uncured adhesive matrices during and/or after the joining of workpieces leads to the effective dissolution and/or dispersion of adhesion-reducing contamination of the substrate surfaces into the adhesive matrix. In many cases, this can reduce the cost of expensive cleaning processes or quality control measures. More particularly, the effect of the concluding pretreatment and cleaning of the substrates in the adhesive is to preclude any adhesion-reducing recontamination.
Patent CA-2463467-A1 (CA)
Inventor: CHEN WEN-TIEN
IPC: C12Q1/04
Filed: 2002-04-11
Abstract: A novel modified matrix system, mimicking a metastatic environment, that can be used to capture and detect viable cancer and normal cells from tissue flu id samples derived from cancer subjects and which provides effective cell separation for diagnostic and therapeutic applications in treating patients with metastatic diseases.
Patent CA-2464087-A1 (CA)
Inventor: MOROV GEORGY VASILEVICH
IPC: A61B17/32
Filed: 2002-10-17
Abstract: A method for controlling fluid flow in a rotational atherectomy device (10). A  source of fluid is provided through a pump (70) to the rotational atherectomy device, wherein the pump (70) maintains the fluid flow at a minimal rate during a time period when a drive shaft (25) of the device is not rotating. A  first control is activated to increase a rate of the fluid flow and second control is activated to initiate a rotation of the drive shaft (25) during another time period when the fluid flow is at the increased rate.
Patent CA-2464446-A1 (CA)
Inventor: SUGAWARA MASANOBU
IPC: C07C67/31
Filed: 2002-10-24
Abstract: L'invention concerne un procédé de production d'un dérivé d'acide 3,5-dihydroxyhexanoïque optiquement actif par réduction stéréosélective d'un dérivé d'acide 3-oxo-5-hydroxyhexanoïque optiquement actif. La mise en oeuvre de ce procédé ne nécessite ni un réacteur à température très basse, ni un incubateur et le procédé est un procédé simple et économique dans lequel une protection de l'hydroxy en position 5 n'est pas nécessaire. L'hydrogène, très peu onéreux, est utilisé comme agent de réduction, aux fins d'hydrogénation asymétrique d'un dérivé d'acide 3-oxo-5-hydroxyhexanoïque optiquement actif par action catalytique d'un complexe de ruthénium/phosphine optiquement active, notamment le complexe RuBr2BINAP préparé à partir de 2,2'bisdiarylphosphino-1-1'-binaphtyle (BINAP) et d'un complexe de ruthénium, permettant ainsi d'obtenir un dérivé d'acide 3,5-dihydroxyhexanoïque optiquement actif.
Patent CA-2464844-A1 (CA)
Title: Media foundation media processor
Inventor: RUDOLPH ERIC
IPC: G06F7/00
Filed: 2004-04-22
Abstract: A system and method for a media processor separates the functions of topolog y creation and maintenance from the functions of processing data through a topology. Th e system includes a control layer including a topology generating element to generate a topology describing a set of input multimedia streams, one or more sources for the input multimedia streams, a sequence of operations to perform on the multimedia data, and a set of output multimedia streams, and a media processor to govern the passin g of the multimedia data as described in the topology and govern the performance of t he sequence of multimedia operations on the multimedia data to create the set of output multimedia streams. The core layer includes the input media streams, the sources for th e input multimedia streams, one or more transforms to operate on the multimedia data , stream sinks, and media sinks to provide the set of output multimedia streams.
Patent CA-2465368-A1 (CA)
Title: Optical anti-glare device
Inventor: BRAUN UWE PETER
IPC: B60Q3/02
Filed: 2001-11-19
Abstract: The invention relates to an optical glare limiter, particularly for motor vehicles, comprising an opto-receiver module (2) and a light source (3) whos e luminous radiation can be regulated according to the luminous radiation of a source of glare. The aim of the invention is to obtain an optical glare limiter of the aforementioned type with a relatively large surface that is homogeneously luminous to a considerable extent despite its compact flat dimensions. To this end, a flat optical waveguide (5), which has at least on e narrow lateral face (6) and a flat light exit surface (10), is assigned to t he light source (3), whereby the light of the light source (3) can be launched via the narrow lateral face (6), and the area of the light exit surface (10) is a multiple of the area of the narrow lateral face used for launching ligh t. Another embodiment of the inventive optical glare limiter is one in which th e light source consists of a luminous film that can be excited by electronics in such a manner that the luminous film represents a surface that is, in essenc e, homogeneously luminous. A further embodiment of the inventive optical glare limiter is one in which the light source consists of organic light-emitting diodes that are mounted on at least one support made of glass or on at least one flexible transparent support made of plastic.
Patent CA-2467866-A1 (CA)
Title: Circular anastomosis device
Inventor: ROBERTSON JOHN CHARLES
IPC: A61B17/03
Filed: 1994-09-26
Abstract: A surgical instrument is disclosed which includes a housing having proximal and distal end portions, a shaft extending from the housing distal end portion, the shaft having proximal and distal end portions, a fastener carrying cartridge positioned at the shaft distal end portion, the cartridge having a plurality of fasteners disposed therein, a fastener firing member operatively associated with the fastener carrying cartridge, at least one lever extending from the housing, the lever being adapted to move the fastener firing member to expel the fasteners from the cartridge, an anvil member disposed opposite the cartridge, an elongated member operatively associated with the anvil member for moving the anvil member relative to the cartridge, and locking means disposed within the housing for locking the elongated member, and, therefore the anvil member, the locking means being movable between at least a first position and a second position such that when the locking means is in the first position the elongated member is movable and when the locking means is in the second position the elongated member is prevented from moving.
Patent CA-2469136-A1 (CA)
Title: Sleeved ultrasonic transducer
Inventor: GOODSON J MICHAEL
IPC: B06B1/06
Filed: 2003-09-22
Abstract: A sleeved ultrasonic transducer (40) has a two-part head mass (42), including a threaded sleeve (44) and an outer housing (46) that are composed of different materials. The threaded sleeve (44) is preferably a metal such as titanium that provides superior thread strength for mating with a compression bolt (24), while the outer housing (46) is preferably aluminum or ceramic or other metal or non-metallic material that provides good thermal heat sink capacity and/or transmission of vibrational energy. The combination of the two components (44, 46) provides an improved ultrasonic transducer.